載入...
Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium
BACKGROUND: Support for early detection of lung cancer has emerged from the National Lung Screening Trial (NLST), in which low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20 % relative to chest x-ray. The US Preventive Services Task Force (USPSTF) recently recommended...
Na minha lista:
| 發表在: | Clin Proteomics |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4537594/ https://ncbi.nlm.nih.gov/pubmed/26279647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-015-9090-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|